Stride Inc. Surpasses Analyst Target: What Does It Mean for Investors?
Stride Inc (Symbol: LRN) has recently seen its shares climb above the average analyst 12-month target price of $86.00, currently trading at $89.71 per share. When a stock reaches its analyst-set target, the next steps can vary. Analysts typically either downgrade the stock due to valuation or adjust their targets higher. How they react might also depend on recent developments within the company that could be driving the stock upward. If the outlook for Stride is positive, it may be time to consider raising the target price.
Within the Zacks coverage universe, there are five different analyst targets contributing to the average for Stride Inc. However, while the average is useful, it doesn’t capture all perspectives. Some analysts have set lower targets, with one anticipating a price of $74.00, while another is much more optimistic with a target of $94.00. The standard deviation among these figures stands at $8.00, showing some variability in expectations.
The purpose of looking at the average price target lies in the collective insights of all analysts involved, rather than relying solely on one expert’s opinion. With LRN trading above the average target price of $86.00/share, investors are now prompted to evaluate the company themselves. The critical question they face is whether $86.00 is just a stepping stone to an even higher target or if the current valuation suggests it’s a good time to take some profits. Below is a summary of the current analyst ratings for Stride Inc:
| Recent LRN Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 4 | 4 | 4 | 4 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 2 | 2 | 2 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.67 | 1.67 | 1.67 | 1.4 |
The average rating, as shown in the last row, ranges from 1 to 5, where 1 is a Strong Buy and 5 is a Strong Sell. This analysis is based on data provided by Zacks Investment Research via Quandl.com. For further insights, consider reviewing the latest Zacks research report on LRN — available for free.
10 ETFs With Most Upside To Analyst Targets »
Additional Resources:
• CSR market cap history
• EGP Insider Buying
• Top Ten Hedge Funds Holding VSDA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
